IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (573)	4/7/1997 11:13:00 PM
From: Roger Cranwill	of 1762

Bennett, et alia- I talked with Connie Matsui today-I called her last week, being curious about what C2B8 would price out at the treatment level. She said there was no concrete figure as yet (of course there must be, just not being let out pending approval) but, she said that the analysts assessment of between $6,000 to $7,000/treatment was probably pretty close. I also asked if there was any feedback on the NDA, and she said that the FDA was content with their paperwork (it hadn't been sent back for not meeting their criteria, so it was coming along nicely... One interesting point she made that the next step the company had to make was another check of production (I thought that was pretty much ironed out before Phase III began, but its another hurdle-probably no problem, I'd think, since the operation seems to be running on a 24 hour schedule. I also asked if it was possible for a numble investor to come to the investment seminar being held this week-Nope-its by strict invitation only-I can't believe we weren't invited! What a letdown-she said we could attend the one in May, though...Anyway, that's the latest from IDEC administration-Roger

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next